Business

Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors

(TheNewswire) Calgary, AB – TheNewswire - J uly 7, 2025 – U...

articleUniversal Ibogaine IncJuly 7, 20254/company/universal-ibogaine-inc/news/universal-ibogaine-advises-of-debt-settlement-with-ceo-and-resignation-of-a-member-of-its-board-of-directors
Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors

About this update from Universal Ibogaine Inc

[{"type":"text","content":"Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, AB –\n \n\n TheNewswire -\nJ\n \n\n uly 7, 2025 – Universal Ibogaine Inc.\n(\n \n\n TSXV:IBO\n \n\n ) (“\n \n\n UI\n \n\n ” or the “\n \n\n Company\n \n\n ”), a life sciences company with a\nmission to research and deliver medicalized ibogaine-centered\naddiction care, advises that Ken Cranwill has resigned from the Board\nof Directors of the Company in order to focus on his other business\nventures.\n \n\n\n\n Nick Karos, CEO and Director, noted “On behalf of the\nBoard of Directors, the Company thanks Ken for his service on the\nBoard over the past year”.\n \n\n\n\n UI also advises that it has received approval from the\nTSX Venture Exchange (the “\n \n\n TSXV\n \n\n ”) to settle a portion, totalling\n$106,200 (the “\n \n\n Debt\n \n\n ”), of arrears consulting fees owed to\nits CEO, Nick Karos.  As previously announced (see News Release dated\nApril 3, 2025) the Company will issue 4,248,000 common shares (subject\nto applicable hold periods), at a price of $0.025 per share in\nsettlement of this Debt.\n \n\n\n\n Following closing of this share issuance, UI will have\na total of 312,858,516 common shares outstanding.\n \n\n\n\n\n About Universal\nIbogaine Inc.\n \n\n\n\n\n\n UI is a life sciences company,\n \n\n\n\n with a mission to\ntransform addiction treatment using medicalized ibogaine through a\nplanned Canadian clinical trial focused on opioid use disorder, and\nultimately to utilize that treatment protocol globally through planned\nfuture licensing agreements.\n \n\n\n\n UI is concurrently developing a state of the art holistic\naddiction treatment protocol at its Kelburn Recovery Centre (located\nnear Winnipeg, Manitoba) that, which when paired with the planned\nibogaine detox protocol, is intended to revolutionize the way we treat\naddiction and drastically improve the lives of individuals and\nfamilies affected by addiction.\n \n\n\n\n\n\n NEITHER THE TSX\nVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS\nDEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS\nRESPONSIBILI...

More updates from Universal Ibogaine Inc